A reassessment of the in-vitro activity of colistin sulphomethate sodium
A reassessment of the in-vitro activity of colistin sulphomethate sodium
复制标题
DOI:
10.1093/jac/39.2.255
复制
发表时间:
1997-02-01
影响因子:
5.2
通讯作者:
Wise, R
中科院分区:
文献类型:
--
作者:
Catchpole, CR;Andrews, JM;Wise, R
The in-vitro activity of colistin sulphomethate sodium was compared with that of other commonly used antimicrobial agents against 377 recent clinical isolates of Gram-negative bacteria (including 94 strains of Pseudomonas aeruginosa from patients with cystic fibrosis) and 16 organisms with defined resistance patterns. Colistin was active against most strains of P. aeruginosa (MIC90 4 mg/L), Shigella spp. (MIC90 0.5 mg/L), Salmonella spp. (MIC90 1 mg/L), Acinetobacter spp. (MIC90 2 mg/L), Citrobacter spp. (MIC90 1 mg/L), Escherichia coli (MIC90 1 mg/L), Klebsiella spp. (MIC90 8 mg/L) and Enterobacter spp. (MIC90 1 mg/L), No useful activity was demonstrated against Providentia spp. or Serratia spp. The results show that colistin remains a useful antimicrobial agent against Gram-negative bacteria, particularly those strains which are resistant to more commonly used antibiotics.